Skip to content

bluebird bio, Inc.

CIK 0001293971

← back to feed
Revenue (TTM)
$83.99M
+188.3% YoY Q1 May 2025
Net Income (TTM)
−$241.07M
−13.6% YoY Q1 May 2025
EPS Diluted (TTM)
−$10.94
+35.6% YoY Q1 May 2025
Gross Margin
6.2%
Q1 May 2025
Operating Margin
-307.9%
Q1 May 2025
Net Margin
-287.0%
Q1 May 2025
Free Cash Flow (TTM)
−$318.5M
Q1 May 2025
Cash
$78.74M
Q1 May 2025
Total Debt
$72.47M
Q1 May 2025
Shares Outstanding
9.79M sh
Q1 May 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings